Taprizosin
Taprizosin (UK-338003) is a selective and orally active α1-adrenoceptor antagonist for vasodilatation in the treatment of benign prostatic hyperplasia.
Product Specifications
CAS Number
210538-44-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
506.58
Molecular Formula
C25H26N6O4S
Notes
Research use only, not for human use.
Receptor
Adrenergic Receptor
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog